Peter Pfreundschuh, Chief Financial Officer at Immunomedics, holds 175.67K shares in Voyager Therapeutics (Ticker: VYGR), holds 8.93K shares in Korro Bio (Ticker: KRRO), holds 10.40K shares in Urogen Pharma (Ticker: URGN). Most recently, Peter Pfreundschuh Sold ― shares of Voyager Therapeutics on Feb 22, 2024 for an estimated value of 28.08K.